- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Perrigo Confirms Papa Exit
April 25, 2016.
Following their refusal to comment Friday on "rumors" that CEO Joseph Papa was leaving to head Valeant Pharmaceuticals, Dublin-based Perrigo has today confirmed the rumor's truth in announcing the appointment of John T. Hendrickson as Perrigo's Chief Executive Officer, "effective immediately, following the resignation and departure of Joseph C. Papa".
Hendrickson has served as President of Perrigo since October 2015. He was formerly Executive Vice President, Global Operations & Supply Chain between 2006 and 2015. Meanwhile, Valeant announced today that Papa tis expected to join the company as Chairman and CEO by early May.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.
